Literature DB >> 12667690

Evaluation of rat intestinal absorption data and correlation with human intestinal absorption.

Yuan H Zhao1, Michael H Abraham, Joelle Le, Anne Hersey, Chris N Luscombe, Gordon Beck, Brad Sherborne, Ian Cooper.   

Abstract

The absorption of 111 drug and drug-like compounds was evaluated from 111 references based on the ratio of urinary excretion of drugs following oral and intravenous administration to intact rats and biliary excretion of bile duct-cannulated rats. Ninety-eight drug compounds for which both human and rat absorption data were available were selected for correlation analysis between the human and rat absorption. The result shows that the extent of absorption in these two species is similar. For 94% of the drugs the absorption difference between humans and rats is less than 20% and for 98% of drugs the difference is less than 30%. There is only one drug for which human absorption is significantly different from rat absorption. The standard deviation is 11% between human and rat absorption. The linear relationship between human and rat absorption forced through the origin, as determined by least squares regression, is %Absorption (human)=0.997%Absorption (rat) (n=98, SD=11). It is suggested that the absorption in rats could be used as an alternative method to human absorption in pre-clinical oral absorption studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667690     DOI: 10.1016/s0223-5234(03)00015-1

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  14 in total

Review 1.  Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.

Authors:  Xianhua Cao; Seth T Gibbs; Lanyan Fang; Heather A Miller; Christopher P Landowski; Ho-Chul Shin; Hans Lennernas; Yanqiang Zhong; Gordon L Amidon; Lawrence X Yu; Duxin Sun
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

2.  Fasting increases tobramycin oral absorption in mice.

Authors:  Luigina De Leo; Nicola Di Toro; Giuliana Decorti; Noelia Malusà; Alessandro Ventura; Tarcisio Not
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

3.  Stabilization and improved in vivo performance of amorphous etoricoxib using Gelucire 50/13.

Authors:  Shamkant L Shimpi; Bhaskar Chauhan; K R Mahadik; Anant Paradkar
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

4.  Development of an in vitro rat intestine segmental perfusion model to investigate permeability and predict oral fraction absorbed.

Authors:  Marc-Etienne Castella; Marianne Reist; Joachim M Mayer; Jean-Jacques Turban; Bernard Testa; Claire Boursier-Neyret; Bernard Walther; Jean-Marie Delbos; Pierre-Alain Carrupt
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

5.  Improved bioavailability of orally administered andrographolide from pH-sensitive nanoparticles.

Authors:  Bothiraja Chellampillai; Atmaram Pandurang Pawar
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2010-12-30       Impact factor: 2.441

6.  What are the digestion and absorption models used to reproduce gastrointestinal protein processes?: A protocol for systematic review.

Authors:  Anna Beatriz Santana Luz; Rafael Oliveira de Araújo Costa; Gidyenne Christine Bandeira Silva de Medeiros; Grasiela Piuvezam; Thais Souza Passos; Ana Heloneida de Araújo Morais
Journal:  Medicine (Baltimore)       Date:  2021-07-30       Impact factor: 1.817

7.  Opportunities and challenges related to saturation of toxicokinetic processes: Implications for risk assessment.

Authors:  Yu-Mei Tan; Hugh A Barton; Alan Boobis; Rachel Brunner; Harvey Clewell; Rhian Cope; Jeffrey Dawson; Jeanne Domoradzki; Peter Egeghy; Pankaj Gulati; Brandall Ingle; Nicole Kleinstreuer; Kelly Lowe; Anna Lowit; Elizabeth Mendez; David Miller; Jeffrey Minucci; James Nguyen; Alicia Paini; Monique Perron; Katherine Phillips; Hua Qian; Tharacad Ramanarayanan; Fiona Sewell; Philip Villanueva; John Wambaugh; Michelle Embry
Journal:  Regul Toxicol Pharmacol       Date:  2021-10-28       Impact factor: 3.598

8.  Interspecies modeling and prediction of human exenatide pharmacokinetics.

Authors:  Ting Chen; Donald E Mager; Leonid Kagan
Journal:  Pharm Res       Date:  2012-11-15       Impact factor: 4.200

9.  Dietary modulation and structure prediction of rat mucosal pentraxin (Mptx) protein and loss of function in humans.

Authors:  Cindy van der Meer-van Kraaij; Roland Siezen; Evelien Kramer; Marjolein Reinders; Hans Blokzijl; Roelof van der Meer; Jaap Keijer
Journal:  Genes Nutr       Date:  2007-10-16       Impact factor: 5.523

10.  The use of ROC analysis for the qualitative prediction of human oral bioavailability from animal data.

Authors:  Andrés Olivares-Morales; Oliver J D Hatley; David Turner; Aleksandra Galetin; Leon Aarons; Amin Rostami-Hodjegan
Journal:  Pharm Res       Date:  2013-09-27       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.